Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript
Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9.
Stay updated with breaking news from Stuart Essig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript February 28, 2024 Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9. Integra LifeSciences Holdings Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
Integra LifeSciences (Nasdaq: IART) announced today that President and CEO Jan De Witte informed the board of his intention to retire.
By Will Feuer Integra LifeSciences Holdings Chief Executive Jan De Witte said he plans to retire this year after less than three years at the helm of the...
Integra LifeSciences Holdings Corporation (IART) reported fourth quarter GAAP net income of $19.8 million, or $0.25 per share, compared to $52.9 million, or $0.63 per share, in the prior year.